.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
UBS
Fish and Richardson
McKinsey
Federal Trade Commission
Accenture
Moodys
US Department of Justice
Harvard Business School
Chinese Patent Office

Generated: June 24, 2017

DrugPatentWatch Database Preview

INTRALIPID 20% Drug Profile

« Back to Dashboard

Which patents cover Intralipid 20%, and when can generic versions of Intralipid 20% launch?

Intralipid 20% is a drug marketed by Fresenius and is included in two NDAs.

The generic ingredient in INTRALIPID 20% is soybean oil. There are thirteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the soybean oil profile page.

Summary for Tradename: INTRALIPID 20%

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Clinical Trials: see list49
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INTRALIPID 20% at DailyMed

Pharmacology for Tradename: INTRALIPID 20%

Ingredient-typeLipids
Drug ClassLipid Emulsion
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius
INTRALIPID 20%
soybean oil
INJECTABLE;INJECTION020248-001Aug 7, 1996APRXYesYes► Subscribe► Subscribe
Fresenius
INTRALIPID 20%
soybean oil
INJECTABLE;INJECTION018449-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Baxter
Colorcon
Argus Health
Accenture
McKesson
Cipla
Harvard Business School
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot